Causality Assessment of Cutaneous Adverse Drug Reactions
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background: Cutaneous adverse drug reactions (ADRs) are the most common adverse reactions attributed to drugs. A systematic and effective approach to a patient with suspected drug eruption allows for prompt recognition, classification and treatment of cutaneous ADRs. A standardized and effective approach for objective causality assessment is necessary to make consistent and accurate identification of ADRs. Objective: Although the Naranjo algorithm is the most widely used assessment tool, it contains many components which are not suitable for clinical assessment of ADRs in Korea. The purpose of this study is to compare correlations of the Naranjo algorithm and the Korean algorithm to evaluate usefulness of both algorithms in order to make a causal link between drugs and cutaneous ADRs. In addition, this study classifies the clinical types and causative agents of cutaneous ADRs. Methods: The authors retrospectively reviewed the clinical types and laboratory findings of patients who were diagnosed with cutaneous ADRs in the dermatology clinic at Gil hospital. One hundred forty-one patients were enrolled in this evaluation. The causal relationship of ADRs was assessed by using the Naranjo algorithm and Korean algorithm (version 2.0). Results: A cross-tabulation analysis was applied to the Naranjo algorithm and Korean algorithm (version 2.0). Simple correlation analysis and a Bland-Altman plot were used for statistical analysis. Correlation analysis confirmed that the two assessment algorithms were significantly correlated. Exanthematous eruptions (68.8%), Stevens-Johnson syndrome (10.6%), and urticaria (8.5%) were the most common types of cutaneoues ADRs. The most common causative agents were antibiotics/antimicrobials,antipyretics/non-steroidal anti-inflammatory drugs, and central nervous system depressants. Conclusion: The Naranjo algorithm and Korean algorithm (version 2.0) were significantly correlated with each other, and thus reliable assessment methods to determine cutaneous ADRs. (Ann Dermatol 23(4) 432∼438, 2011)
Abstract
Background: Cutaneous adverse drug reactions (ADRs) are the most common adverse reactions attributed to drugs. A systematic and effective approach to a patient with suspected drug eruption allows for prompt recognition, classification and treatment of cutaneous ADRs. A standardized and effective approach for objective causality assessment is necessary to make consistent and accurate identification of ADRs. Objective: Although the Naranjo algorithm is the most widely used assessment tool, it contains many components which are not suitable for clinical assessment of ADRs in Korea. The purpose of this study is to compare correlations of the Naranjo algorithm and the Korean algorithm to evaluate usefulness of both algorithms in order to make a causal link between drugs and cutaneous ADRs. In addition, this study classifies the clinical types and causative agents of cutaneous ADRs. Methods: The authors retrospectively reviewed the clinical types and laboratory findings of patients who were diagnosed with cutaneous ADRs in the dermatology clinic at Gil hospital. One hundred forty-one patients were enrolled in this evaluation. The causal relationship of ADRs was assessed by using the Naranjo algorithm and Korean algorithm (version 2.0). Results: A cross-tabulation analysis was applied to the Naranjo algorithm and Korean algorithm (version 2.0). Simple correlation analysis and a Bland-Altman plot were used for statistical analysis. Correlation analysis confirmed that the two assessment algorithms were significantly correlated. Exanthematous eruptions (68.8%), Stevens-Johnson syndrome (10.6%), and urticaria (8.5%) were the most common types of cutaneoues ADRs. The most common causative agents were antibiotics/antimicrobials,antipyretics/non-steroidal anti-inflammatory drugs, and central nervous system depressants. Conclusion: The Naranjo algorithm and Korean algorithm (version 2.0) were significantly correlated with each other, and thus reliable assessment methods to determine cutaneous ADRs. (Ann Dermatol 23(4) 432∼438, 2011)
참고문헌 (28)
- Shear NH, "Cutaneous reactions to drugs. In Fitzpatrick’s dermatology in general medicine. 7th ed", pp.355~362 (2008), New York: McGraw-Hill
- James WD, "Andrews’ disease of the skin. 10th ed", pp.115~138 (2006), Philadelphia: WB Saunders
- Knowles SR, "Cutaneous drug reactions with systemic features. In Comprehensive dermatologic drug therapy. 2nd ed", pp.977~988 (2007), Indianapolis: Saunders Elsevier
- Revuz J, "Drug reaction. In Dermatology. 1st ed", pp.333~353 (2003), Philadelphia: Mosby
- 권경술, "최근 10년간 약진 환자 중 호산구 증가증 및 전신증상을 동반한 약진(DRESS)의 임상적 고찰", 대한피부과학회지, 43(9), pp.1164~1169 (2005), 대한피부과학회
- Roujeau JC, "Severe adverse cutaneous reactions to drugs", N Engl J Med, 331, pp.1272~1285 (1994)
- Bachot N, "Differential diagnosis of severe cutaneous drug eruptions", Am J Clin Dermatol, 4, pp.561~572 (2003)
- Roujeau JC, "Treatment of severe drug eruptions", J Dermatol, 26, pp.718~722 (1999)
- Johnson JA, "Drug-related morbidity and mortality. A cost-of-illness model", Arch Intern Med, 155, pp.1949~1956 (1995)
- Kim KJ, "Clinical study and skin tests of patients with drug eruption", Korean J Dermatol, 36, pp.887~896 (1998)
- Shin KS, "Clinical study of hospitalized patients with drug eruption during a 10-year reriod (1975-1985)", Korean J Dermatol, 25, pp.176~182 (1987)
- Kim SN, "Clinical study for drug eruptions", Korean J Dermatol, 16, pp.377~381 (1978)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- 홍경섭, "약물이상반응의 인과성 평가를 위한 한국형 알고리즘의 개발", 임상약리학회지, 10(2), pp.129~142 (2002), 대한임상약리학회
- Franceschi M, "Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients", Drug Saf, 31, pp.545~556 (2008)
- Davies EC, "Adverse drug reactions in hospitals: a narrative review", Curr Drug Saf, 2, pp.79~87 (2007)
- Lazarou J, "Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies", JAMA, 279, pp.1200~1205 (1998)
- Bang DS, "Statistical study of dermatoses during the last 5 years (1976∼1980)", Korean J Dermatol, 21, pp.37~44 (1983)
- Hahm JH, "A comparative study on clinical evaluation of inpatient dermatology consultation between 1976 and 1991", Korean J Dermatol, 30, pp.651~658 (1992)
- Becquemont L, "Pharmacogenomics of adverse drug reactions: practical applications and perspectives", Pharmacogenomics, 10, pp.961~969 (2009)
- 이승미, "약물감시를 위한 실마리정보 파악 및 인과관계 평가", 임상약리학회지, 13(2), pp.121~133 (2005), 대한임상약리학회
- Moore N, "Adverse drug reaction monitoring: doing it the French way", Lancet, 2, pp.1056~1058 (1985)
- Danan G, "Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries", J Clin Epidemiol, 46, pp.1323~1330 (1993)
- Classen DC, "Computerized surveillance of adverse drug events in hospital patients", JAMA, 266, pp.2847~2851 (1991)
- Dormann H, "Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting", Drug Saf, 22, pp.161~168 (2000)
- Hogan DJ, "Morbilliform drug eruptions", J Am Acad Dermatol, 61, pp.152~ (2009)
- Gerson D, "Cutaneous drug eruptions: a 5-year experience", J Am Acad Dermatol, 59, pp.995~999 (2008)
- Gendernalik SB, "Fixed drug eruptions: a case report and review of the literature", Cutis, 84, pp.215~219 (2009)